• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi , Oct. 31

PANACEA Biotec has recorded net sales of Rs 78.30 crore, a growth of 172 per cent compared to previous year's second quarter net sales of Rs 28.76 crore.

Net profit after providing for appropriations and tax, stood at Rs 11.10 crore .

For the half-year ended September 30, revenues were at Rs 179.16 crore and net profit at Rs 19.84 crore.

During the quarter, the company has added 3 new brands to its basket, namely Heartfelt (natural product for Cholesterol management), Nimulid SafeInject (for management of Post Operative Pain) and Willgo (for 24 hour management of Pain, Inflammation and Fever). Nimulid Safeinject and Willgo have been patented by the company worldwide.

More Stories on : Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Natco Pharma Q2 profit up 10 pc

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line